Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazyar Shadman

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Transplantation and Cellular Therapy|February 9, 2023
Allogenic Hematopoietic Cell Transplantation after CAR-T Failure: When Your Old Friend Comes to RescueMazyar Shadman
JAMA|March 21, 2023
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A ReviewMazyar Shadman
Blood|May 11, 2019
Concurrent diagnosis of classical Hodgkin lymphoma and Langerhans cell histiocytosisLorena Panaite, Mazyar Shadman
Blood|January 14, 2021
Vaccinations in CLL: implications for COVID-19Mazyar Shadman, Chaitra Ujjani
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Improving Outcomes for Patients With Chronic Lymphocytic LeukemiaMazyar Shadman, Amy Goodrich
Hematology/Oncology Clinics of North America|July 11, 2025
First-line Therapy: Time-Limited Venetoclax Doublet TherapyJennifer Huang, Mazyar Shadman
Expert Review of Hematology|August 20, 2024
BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemiaAlycia Hatashima, Mazyar Shadman
Current Treatment Options in Oncology|March 15, 2020
Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing LandscapeLorenzo Iovino, Mazyar Shadman
Cancer Management and Research|March 21, 2023
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of MosunetuzumabPaolo Lopedote, Mazyar Shadman
Clinical Advances in Hematology & Oncology : H&O|March 3, 2023
CAR T-cell therapy for CLL: a new addition to our treatment toolbox?Lorenzo Iovino, Mazyar Shadman
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Transplantation and Cellular Therapy|February 9, 2023
Allogenic Hematopoietic Cell Transplantation after CAR-T Failure: When Your Old Friend Comes to RescueMazyar Shadman
JAMA|March 21, 2023
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A ReviewMazyar Shadman
Blood|May 11, 2019
Concurrent diagnosis of classical Hodgkin lymphoma and Langerhans cell histiocytosisLorena Panaite, Mazyar Shadman
Blood|January 14, 2021
Vaccinations in CLL: implications for COVID-19Mazyar Shadman, Chaitra Ujjani
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Improving Outcomes for Patients With Chronic Lymphocytic LeukemiaMazyar Shadman, Amy Goodrich
Hematology/Oncology Clinics of North America|July 11, 2025
First-line Therapy: Time-Limited Venetoclax Doublet TherapyJennifer Huang, Mazyar Shadman
Expert Review of Hematology|August 20, 2024
BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemiaAlycia Hatashima, Mazyar Shadman
Current Treatment Options in Oncology|March 15, 2020
Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing LandscapeLorenzo Iovino, Mazyar Shadman
Cancer Management and Research|March 21, 2023
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of MosunetuzumabPaolo Lopedote, Mazyar Shadman
Clinical Advances in Hematology & Oncology : H&O|March 3, 2023
CAR T-cell therapy for CLL: a new addition to our treatment toolbox?Lorenzo Iovino, Mazyar Shadman
Pageof 23